Adage Capital Partners GP L.L.C. Purchases 102,099 Shares of Amedisys, Inc. (NASDAQ:AMED)

Adage Capital Partners GP L.L.C. increased its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 32.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 418,002 shares of the health services provider's stock after purchasing an additional 102,099 shares during the period. Adage Capital Partners GP L.L.C. owned approximately 1.28% of Amedisys worth $37,950,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Blue Trust Inc. raised its position in shares of Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after buying an additional 124 shares in the last quarter. HBW Advisory Services LLC bought a new position in Amedisys in the fourth quarter valued at approximately $38,000. Versant Capital Management Inc lifted its stake in Amedisys by 68.5% during the fourth quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after purchasing an additional 183 shares during the last quarter. Vestcor Inc bought a new position in shares of Amedisys in the 4th quarter valued at $73,000. Finally, Venturi Wealth Management LLC raised its holdings in shares of Amedisys by 397.4% during the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock worth $89,000 after buying an additional 779 shares in the last quarter. Institutional investors and hedge funds own 94.36% of the company's stock.

Amedisys Stock Performance

Shares of NASDAQ AMED traded down $0.41 during midday trading on Wednesday, hitting $94.31. The company's stock had a trading volume of 29,164 shares, compared to its average volume of 405,518. The firm has a market capitalization of $3.09 billion, a price-to-earnings ratio of 37.42, a P/E/G ratio of 1.78 and a beta of 0.89. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a fifty day moving average price of $92.32 and a 200 day moving average price of $91.76. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. The company had revenue of $594.78 million during the quarter, compared to analyst estimates of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Amedisys's revenue was up 4.1% compared to the same quarter last year. During the same period last year, the business earned $1.03 earnings per share. On average, research analysts forecast that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

AMED has been the subject of several research reports. Royal Bank of Canada reissued an "outperform" rating and issued a $100.00 price objective on shares of Amedisys in a research note on Wednesday, April 16th. Stephens reaffirmed an "equal weight" rating and issued a $101.00 target price on shares of Amedisys in a report on Tuesday, March 4th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.